The price of progress: Funding and financing Alzheimer's disease drug development

INTRODUCTION: Advancing research and treatment for Alzheimer's disease (AD) and the search for effective treatments depend on a complex financial ecosystem involving federal, state, industry, advocacy, venture capital, and philanthropy funding approaches. METHODS: We conducted an expert review...

Descripción completa

Detalles Bibliográficos
Autores principales: Cummings, Jeffrey, Reiber, Carl, Kumar, Parvesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Special Issue from the Centers of Biomedical Research Excellence (COBRE) and Center for Neurodegeneration and Translational Neuroscience (CNTN)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118094/
https://www.ncbi.nlm.nih.gov/pubmed/30175227
http://dx.doi.org/10.1016/j.trci.2018.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118094/
https://www.ncbi.nlm.nih.gov/pubmed/30175227
http://dx.doi.org/10.1016/j.trci.2018.04.008

Ejemplares similares